Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Heaphy

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Oncotarget|October 19, 2018
Genetic alterations associated with ALTered telomeresJacqueline A Brosnan-Cashman, Mindy K Graham, Christopher M Heaphy
Journal of Clinical Pathology|October 27, 2023
Alternative lengthening of telomeres: mechanism and the pathogenesis of cancerJoakin O Mori, Joshua Keegan, Rachel L Flynn, et al.
Acta Neuropathologica|September 22, 2016
Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomasFausto J Rodriguez, M Adelita Vizcaino, Jaishri Blakeley, et al.
Cancer Medicine|January 24, 2013
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomasKimberly S Butler, William C Hines, Christopher M Heaphy, et al.
Human Pathology|June 21, 2015
Telomere length alterations unique to invasive lobular carcinomaChristopher M Heaphy, Rebecca Asch-Kendrick, Pedram Argani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Telomere DNA content predicts breast cancer-free survival intervalChristopher M Heaphy, Kathy B Baumgartner, Marco Bisoffi, et al.
Human Pathology|August 30, 2024
Gradual telomere shortening in the tumorigenesis of pancreatic and hepatic mucinous cystic neoplasmsYou-Na Sung, Marija Stojanova, Seungbeom Shin, et al.
The Journal of Pathology|November 9, 2021
Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumorsKoen Ma Dreijerink, Wenzel M Hackeng, Aatur D Singhi, et al.
Cancer Cell International|June 2, 2006
Protease nexin-1 expression is altered in human breast cancerBritny J Candia, William C Hines, Christopher M Heaphy, et al.
The American Journal of Surgical Pathology|May 21, 2019
Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian CancerShiho Asaka, Christine Davis, Shiou-Fu Lin, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Oncotarget|October 19, 2018
Genetic alterations associated with ALTered telomeresJacqueline A Brosnan-Cashman, Mindy K Graham, Christopher M Heaphy
Journal of Clinical Pathology|October 27, 2023
Alternative lengthening of telomeres: mechanism and the pathogenesis of cancerJoakin O Mori, Joshua Keegan, Rachel L Flynn, et al.
Acta Neuropathologica|September 22, 2016
Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomasFausto J Rodriguez, M Adelita Vizcaino, Jaishri Blakeley, et al.
Cancer Medicine|January 24, 2013
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomasKimberly S Butler, William C Hines, Christopher M Heaphy, et al.
Human Pathology|June 21, 2015
Telomere length alterations unique to invasive lobular carcinomaChristopher M Heaphy, Rebecca Asch-Kendrick, Pedram Argani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Telomere DNA content predicts breast cancer-free survival intervalChristopher M Heaphy, Kathy B Baumgartner, Marco Bisoffi, et al.
Human Pathology|August 30, 2024
Gradual telomere shortening in the tumorigenesis of pancreatic and hepatic mucinous cystic neoplasmsYou-Na Sung, Marija Stojanova, Seungbeom Shin, et al.
The Journal of Pathology|November 9, 2021
Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumorsKoen Ma Dreijerink, Wenzel M Hackeng, Aatur D Singhi, et al.
Cancer Cell International|June 2, 2006
Protease nexin-1 expression is altered in human breast cancerBritny J Candia, William C Hines, Christopher M Heaphy, et al.
The American Journal of Surgical Pathology|May 21, 2019
Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian CancerShiho Asaka, Christine Davis, Shiou-Fu Lin, et al.
Pageof 12